¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"symmetric disulfide"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • symmetric gangrene
    ´ëα«Àú
  • carbon disulfide
    ÀÌȲȭź¼Ò
  • disulfide
    ÀÌȲȭ¹°
  • disulfide bond
    ÀÌȲ°áÇÕ
  • hydrogen disulfide
    ÀÌȲȭ¼ö¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • disulfide bond
    µð¼³Çǵå°áÇÕ
  • carbon disulfide
    ÀÌȲȭź¼Ò
  • disulfide
    ÀÌȲȭ¹°
  • hydrogen disulfide
    ÀÌȲȭ¼ö¼Ò
  • symmetric gangrene
    ´ëα«Àú
  • symmetric hypertrophy
    ´ëĪºñ´ë
  • parallel symmetric twin
    ÆòÇà´ëνֵÕÀÌ
  • symmetric tonic neck reflex
    ´ëαäÀå¸ñ¹Ý»ç
  • symmetric twin
    ´ëνֵÕÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hydrogen disulfide
    ÀÌȲȭ¼ö¼Ò.
  • progressive symmetric erythrokeratodermia
    ÁøÇ༺ ´ëμº È«»ö °¢ÇÇÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbon disulfide
    ÀÌȲȭ(ì£üÜûù)ź¼Ò.
  • carbon disulfide poisoning
    ÀÌȲȭź¼ÒÁßµ¶(¡­ñéÔ¸).
  • disulfide
    ÀÌȲȭ¹°(ì£üÜûùÚª).
  • disulfide bond
    µð¼³Çǵå<ÀÌȲȭ>°áÇÕ
  • disulfide bond
    µð¼³Çǵå<ÀÌȲȭ>°áÇÕ (¡­Ì¿ùê).
  • hydrogen disulfide
    ÀÌȲȭ¼ö¼Ò.
  • nickel disulfide
    ÀÌȲȭ(ì£üÜûù)´ÏÄÌ.
  • benign symmetric lipomatosis
    ¾ç¼º ´ëμºÁö¹æÁ¾Áõ
  • parallel symmetric twin
    ÆòÇà´ëνÖžÆ
  • progressive symmetric erythrokeratodermia
    ÁøÇ༺ ´ëμº È«»ö °¢ÇÇÁõ
  • symmetric field
    ´ëĪÁ¶»ç¿µ¿ª
  • symmetric gangrene
    ´ëμº ±«Àú(¡­±«Àú).
  • symmetric gangrene
    ´ëμº ±«Àú(¡­ÎÕîÅ)
  • symmetric hypertrophy (gigantism)
    ´ëĪºñ´ë(°Å´ëÁõ)
  • symmetric keratoderma
    ´ëμº °¢ÇÇÁõ (¡­ÊÇù«ñø)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Transverse symmetric twin
    °¡·Î´ëνÖžÆ
    [¿¾ ¿ë¾î] ȾÇà´ëμº½ÖÅÂ
  • Parallel symmetric twin
    ÆòÇà´ëνÖžÆ
    [¿¾ ¿ë¾î] ÆòÇà´ëμº½ÖÅÂ
  • Symmetric twin
    ´ëνÖžÆ
    [¿¾ ¿ë¾î] ´ëμº½ÖÅÂ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • symmetric transcription
    ´ëĪÀü»ç (Óßöàï®ÞÐ)
  • disulfide
    ÀÌȲȭ¹°(ì£üÜûùÚª)
  • disulfide bond
    ÀÌȲ°áÇÕ(ì£üÜÌ¿ùê)
  • disulfide bridge
    "ÀÌȲ °¡±³(ì£üÜÊ­Îé), (ÔÒ) disulfide bond"
  • disulfide interchange
    ÀÌȲȭ¹°±³È¯(ì£üÜü§ÚªÎßüµ)
  • disulfide link
    "ÀÌȲ ¿¬°á(ì£üÜÖ§Ì¿), (ÔÒ) disulfide bond"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • symmetric(al)
    ´ëĪ(¼º)ÀÇ, ´ëÃø(¼º)ÀÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DDD AV universal [pacemaker]; defined daily dose; degenerative disc disease; dehydroxydinaphthyl disulfi...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
ASP abnormal spinal posture; acute symmetric polyarthritis; African swine pox; aged substrate plasma; al...
BSL benign symmetric lipomatosis; blood sugar level
MSL midsternal line; multiple symmetric lipomatosis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MSL Multiple Symmetric Lipomatosis
CS2 Carbon Disulfide
DADS Diallyl disulfide
DMDS Dimethyl disulfide
dsFv Disulfide-stabilized Fv
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • carbon disulfide poisoning
    ÀÌȲȭ ź¼Ò Áßµ¶
    ÀÌȲȭ ź¼Ò¿¡ ³ëÃâµÇ¾î »ý±â´Â Àü½Å ¼è¾à, ºÒ¸é, ½Ã·Â Àå¾Ö¸¦ Ư¡À¸·Î ÇÏ´Â Áßµ¶ Áõ¼¼.
  • hydrogen disulfide
    ÀÌȲȭ ¼ö¼Ò
  • symmetric
    ´ëĪÀÇ, ´ëμºÀÇ, ´ëÃøÀÇ, ´ëÃø¼ºÀÇ
  • symmetric gangrene
    ´ëμº ±«Àú
  • symmetric keratoderma
    ´ëμº °¢ÇÇÁõ
  • symmetric torsion
    ´ëĪ ¿°Àü
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
symmetric disulfide Disulfide that is symmetric on both sides of the -s-s- linkage; i.e., disulfide formed from identical thiol-containing compounds; e.g., cystine, glutathione disulfide.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
multiple symmetric lipomatosis Accumulation and progressive enlargement of collections of adipose tissue in the subcutaneous tissue of the head, neck, upper trunk, and upper portions of the upper extremities; seen primarily in adult males and of unknown cause.
Synonym: Launois-Bensaude syndrome, Madelung's disease, symmetric adenolipomatosis.
(05 Mar 2000)
pseudo-symmetric <chemistry> Exhibiting pseudo-symmetry.
Source: Websters Dictionary
(01 Mar 1998)
symmetric adenolipomatosis Accumulation and progressive enlargement of collections of adipose tissue in the subcutaneous tissue of the head, neck, upper trunk, and upper portions of the upper extremities; seen primarily in adult males and of unknown cause.
Synonym: Launois-Bensaude syndrome, Madelung's disease, symmetric adenolipomatosis.
(05 Mar 2000)
symmetric asphyxia <syndrome> Idiopathic paroxysmal bilateral cyanosis of the digits due to arterial and arteriolar contraction; caused by cold or emotion.
See: Raynaud's phenomenon.
Synonym: Raynaud's disease, symmetric asphyxia.
(05 Mar 2000)
symmetric distal neuropathy <neurology> A disease process involving a number of peripheral nerves.
Origin: Gr. Pathos = disease
(14 Oct 1997)
asymmetric disulfide <chemistry> Disulfide which is not symmetric on both sides of the -s-s- linkage; e.g., the disulfide formed between coenzyme A and glutathione or between cysteine and coenzyme A or glutathione.
Synonym: asymmetric disulfide.
(05 Mar 2000)
carbon disulfide <chemical> Carbon disulfide (cs2). A colourless, flammable, poisonous liquid, cs2. It is used as a solvent, and is a counterirritant and has local anaesthetic properties but is not used as such. It is highly toxic with pronounced CNS, haematologic, and dermatologic effects.
Chemical name: Carbon disulfide
(12 Dec 1998)
carbon disulfide poisoning Acute or chronic intoxication by CS2, an industrial condition encountered among rubber workers and makers of artificial silk (rayon) by the viscose process; characterised by insomnia, listlessness, and irritability, followed by paralyses, impaired vision, peptic ulcer, and psychoses.
(05 Mar 2000)
carbon monoxide dehydrogenase disulfide reductase <enzyme> Catalyses a reversible exchange of coash with acetyl-CoA in combination with carbon monoxide dehydrogenase (EC 1.2.99.2)
Registry number: EC 1.8.-
Synonym: co dehydrogenase disulfide reductase, co-dd-reductase
(26 Jun 1999)
glutathione disulfide <chemical> A glutathione derivative that forms when the sulfhydryl side chains of the cysteine residues of two glutathione molecules form a disulfide bond during the course of being oxidised with various oxides and peroxides in cells. Glutathione reductase, with the coupled oxidation of NADPH, reduces gssg to two moles of glutathione.
Chemical name: Bis(gamma-Glutamyl-L-cysteinylglycine) Disulfide
(12 Dec 1998)
periplasmic protein disulfide oxidoreductase <enzyme> Isolated from haemophilus influenzae; may be required for assembly or folding of one or more disulfide-containing cell envelope proteins; ccmg isolated from paracoccus denitrificans
Registry number: EC 1.8.4.-
Synonym: por disulfide oxidoreductase, por gene product, periplasmic oxidoreductase, ccmg gene product
(26 Jun 1999)
mixed disulfide <chemistry> Disulfide which is not symmetric on both sides of the -s-s- linkage; e.g., the disulfide formed between coenzyme A and glutathione or between cysteine and coenzyme A or glutathione.
Synonym: asymmetric disulfide.
(05 Mar 2000)
protein disulfide-isomerase <enzyme> An enzyme that catalyses the rearrangement of disulfide bonds within proteins during folding. It is a monomer identical to one of the subunits of procollagen-proline dioxygenase.
Chemical name: Protein disulfide-isomerase
Registry number: EC 5.3.4.1
(12 Dec 1998)
protein disulfide reductase (glutathione) <enzyme> An enzyme that catalyses the reduction of a protein-disulfide in the presence of glutathione, forming a protein-dithiol. Insulin is one of its substrates.
Chemical name: Glutathione:protein-disulfide oxidoreductase
Registry number: EC 1.8.4.2
(12 Dec 1998)
disulfide 1. A molecule containing two atoms of sulfur to one of the reference element, e.g., CS2, carbon disulfide.
2. A compound containing the -S-S-group, e.g., cystine.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • disulfide
    ÀÌȲȭ¹°
  • symmetric
    »óĪÀûÀÎ
  • disulfide
    (È­)2Ȳȭ¹°
  • symmetric
    (Á¿ì)´ëĪÀûÀÎ;±ÕÇüÀâÈù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á